Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole for Cetuximab-Related Skin Toxicity
NCT06118047Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 2 trial of AN2728 ointment vehicle in acneiform eruption, sponsored by Sun Yat-sen University. Started Aug 2023; status: recruiting.
02
Drugs
AN2728 ointment vehicle
03
Conditions
acneiform eruption
Beyond the preview
Go deeper on NCT06118047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118047.